Journal of Inherited Metabolic Disease

, Volume 25, Issue 3, pp 207–214

Primary and secondary defects of the mitochondrial respiratory chain

  • A. H. V. Schapira


Over 100 mutations of mitochondrial DNA (mtDNA) have been associated with human disease. The phenotypic manifestation of mtDNA mutations is extremely broad, from oligosymptomatic patients with isolated deafness, diabetes, ophthalmoplegia, etc., to complex encephalomyopathic disorders that may include dementia, seizures, ataxia, stroke-like episodes, etc. The genotype variants are also wide, with rearrangements (deletions, duplications) and point mutations affecting protein coding genes, tRNAs and rRNAs. There are some broad genotype/phenotype correlations but also substantial overlap. The pathogenetic mechanisms involved in the expression of mtDNA mutations are still not yet fully understood. More recently, mutations of nuclear genes encoding subunits of the respiratory chain, particularly those of complex I, have been identified. These predominantly, but not exclusively, involve infant onset disease with early death. Recently it has become clear that the function of the respiratory chain may be impaired by mutations affecting other mitochondrial proteins or as a secondary phenomenon to other intracellular biochemical derangements. Examples include Friedreich ataxia where a mutation of a nuclear encoded protein (frataxin), probably involved in iron homeostasis in mitochondria, results in severe deficiency of the respiratory chain in a pattern indicative of free radical mediated damage. Mutations of nuclear encoded proteins involved in cytochrome oxidase assembly and maintenance have been characterised and, as predicted, are associated with severe deficiency of cytochrome oxidase and, most frequently, Leigh syndrome. Defects of intracellular metabolism, with particularly excess-free radical generation including nitric oxide or peroxynitrite, may cause secondary damage to the respiratory chain. This is probably of relevance in Huntington disease, motor neuron disease (amyotrophic lateral sclerosis) and Wilson disease. These disorders seem to have defective oxidative phosphorylation as a common pathway in their pathogenesis and it may be that treatments designed to improve respiratory chain function may ameliorate the progression of these disorders.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bradley JL, Blake JC, Chamberlain S, Thomas PK, Cooper JM, Schapira AHV (2000) Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Hum Mol Genet 9: 275–282.Google Scholar
  2. Bourgeron T, Rustin P, Chretien D, et al (1995) Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nature Genetics 11: 144–149.Google Scholar
  3. Kadowaki T, Sakura H, Otabe S, et al (1994) A subtype of diabetes mellitus associated with a mutation in the mitochondrial gene. Muscle Nerve 3: S137-S141.Google Scholar
  4. Kaukonen J, Juselius JK, Tiranti V, et al (2000) Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289: 782–785.Google Scholar
  5. Lodi R, Cooper JM, Bradley JL, et al. (1999) Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc Natl Acad Sci USA 96: 11492–11495.Google Scholar
  6. Lodi R, Hart PE, Rajagopalan B, et al (2001) Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia. Ann Neurol 49: 590–596.Google Scholar
  7. Nishino I, Spinazzola A, Papadimitriou H, et al (2000) Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol 47: 792–800.Google Scholar
  8. Triepels RH, van den Heuvel LP, Trijbels JM, Smeitink JA (2001) Respiratory chain complex I deficiency. Am J Med Genet (Semin Med Genet) 106: 37–45.Google Scholar
  9. Valnot I, Osmond S, Gigarel N, et al (2000a) Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase (COX) deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet 67: 1104–1109.Google Scholar
  10. Valnot I, von Kleist-Retzow JC, Barrientos A, et al (2000b) A mutation in the human heme A:farnesyltransferase gene (COX10)causes cytochrome oxidase deficiency. Hum Mol Genet 9: 1245–1249.Google Scholar
  11. Zeviani M, Servidei S, Gellera C, et al (1989) An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 339: 309–311.Google Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • A. H. V. Schapira
    • 1
  1. 1.University Department of Clinical Neurosciences, Royal Free and University College Medical School and Institute of NeurologyUniversity College LondonLondonUK

Personalised recommendations